Variability in competitive fitness among environmental and clinical azole-resistant Aspergillus fumigatus isolates

Shu Chen,Guoxing Zhu,Huiping Lin,Jian Guo,Shuwen Deng,Wenjuan Wu,Gustavo H Goldman,Ling Lu,Yuanwei Zhang,Gustavo H. Goldman
DOI: https://doi.org/10.1128/mbio.00263-24
IF: 6.4
2024-02-27
mBio
Abstract:ABSTRACT Azoles are the primary antifungal drugs used to treat infections caused by Aspergillus fumigatus . However, the emergence of azole resistance in A. fumigatus has become a global health concern despite the low proportion of resistant isolates in natural populations. In bacteria, antibiotic resistance incurs a fitness cost that renders strains less competitive in the absence of antibiotics. Consequently, fitness cost is a key determinant of the spread of resistant mutations. However, the cost of azole resistance and its underlying causes in A. fumigatus remain poorly understood. In this observation, we revealed that the 10 out of 15 screened azole-resistant isolates, which possessed the most common azole-targeted cyp51A mutations, particularly the presence of tandem repeats in the promoter region, exhibit fitness cost when competing with the susceptible isolates in azole-free environments. These results suggest that fitness cost may significantly influence the dynamics of azole resistance, which ultimately contributes to the low prevalence of azole-resistant A. fumigatus isolates in the environment and clinic. By constructing in situ cyp51A mutations in a parental azole-susceptible strain and reintroducing the wild-type cyp51A gene into the azole-resistant strains, we demonstrated that fitness cost is not directly dependent on cyp51A mutations but is instead associated with the evolution of variable mutations related to conidial germination or other unknown development-related processes. Importantly, our observations unexpectedly revealed that some azole-resistant isolates showed no detectable fitness cost, and some even exhibited significantly increased competitive fitness in azole-free environments, highlighting the potential risk associated with the prevalence of these isolates. IMPORTANCE Azole resistance in the human fungal pathogen Aspergillus fumigatus presents a global public health challenge. Understanding the epidemic trends and evolutionary patterns of azole resistance is critical to prevent and control the spread of azole-resistant isolates. The primary cause is the mutation of the drug target 14α-sterol-demethylase Cyp51A, yet its impact on competitive ability remains uncertain. Our competition assays revealed a diverse range of fitness outcomes for environmental and clinical cyp51A -mutated isolates. We have shown that this fitness cost is not reliant on cyp51A mutations but might be linked to unknown mutations induced by stress conditions. Among these isolates, the majority displayed fitness costs, while a few displayed enhanced competitive ability, which may have a potential risk of spread and the need to closely monitor these isolates. Our observation reveals the variation in fitness costs among azole-resistant isolates of A. fumigatus , highlighting the significant role of fitness cost in the spread of resistant strains.
microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to understand the resistance mechanisms of azole antifungal drugs in the environment and in the clinic, especially to evaluate the impact of these resistance mutations on the competitive fitness of Aspergillus fumigatus. Specifically, the researchers focused on: 1. **Impact of resistance mutations on competitive fitness**: The paper explored the changes in the competitive fitness of Aspergillus fumigatus strains carrying different cyp51A gene mutations (especially tandem repeat sequences and point mutations) in an environment without azole drugs. Through competition experiments, the researchers hoped to determine whether these mutations would lead to fitness costs, as well as the magnitude and frequency of such costs. 2. **Relationship between fitness cost and mutation**: The study further investigated whether the fitness cost was directly caused by the cyp51A gene mutation or was related to other unknown genes or developmental processes. This helps to understand the spread dynamics of resistance mutations in natural and clinical environments. 3. **Diversity of competitive fitness of resistant strains**: The study also revealed that there were significant differences in the competitive fitness among resistant strains from different sources (environmental, clinical, and laboratory - induced), and some strains even showed higher competitiveness, which has a potential risk for the spread of resistance. ### Main findings - **Universality of fitness cost**: Most resistant strains showed fitness costs in an environment without azole drugs, which may be due to the decreased competitiveness of these strains in the absence of drug selection pressure. - **Heterogeneity of fitness cost**: Although most resistant strains showed fitness costs, there were still a few strains without obvious fitness costs and even showed higher competitiveness. - **Fitness cost is not related to cyp51A mutation**: By constructing cyp51A mutants in a homologous background and re - introducing the wild - type cyp51A gene, the study found that the fitness cost was not directly caused by the cyp51A mutation, but may be related to mutations affecting the spore germination rate or other unknown developmental processes. ### Conclusion This study emphasizes the important role of fitness cost in the spread of resistant Aspergillus fumigatus and reveals the diversity of fitness among different resistant strains. These findings are of great significance for understanding the epidemic trends and evolutionary patterns of resistant strains and are helpful for formulating more effective prevention and control strategies.